| Issue Date | Title | Author(s) |
| 2012 | Cholinergic pathways and cognition in patients with schizophrenia : a pilot study | Rajji, Tarek K.; Chow, Tiffany W.; Voineskos, Aristotle N.; Links, Kira A.; Miranda, Dielle; Mamo, David; Ismail, Zahinoor; Pollock, Bruce G.; Mulsant, Benoit H. |
| 2010 | Clozapine and global cognition in schizophrenia | Rajji, Tarek K.; Uchida, Hiroyuki; Ismail, Zahinoor; Ng, Wenzie; Mamo, David; Remington, Gary; Pollock, Bruce G.; Mulsant, Benoit H. |
| 2009 | Clozapine exposure and the impact of smoking and gender : a population pharmacokinetic study | Ng, Wenzie; Uchida, Hiroyuki; Ismail, Zahinoor; Mamo, David; Rajji, Tarek K.; Remington, Gary; Sproule, Beth A.; Pollock, Bruce G.; Mulsant, Benoit H.; Bies, Robert R. |
| 2009 | D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophrenia | Uchida, Hiroyuki; Rajji, Tarek K.; Mulsant, Benoit H.; Kapur, Shitij; Pollock, Bruce G.; Graff-Guerrero, Ariel; Menon, Mahesh; Mamo, David |
| 2012 | Delineating the functional neuroanatomy of illness denial or anosognosia in schizophrenia | Gerretsen, Philip; Graff-Guerrero, Ariel; Mamo, David; Pollock, Bruce G.; Menon, Mahesh |
| 2015 | Dopamine D 2/3 receptor occupancy following dose reduction is predictable with minimal plasma antipsychotic concentrations : an open-label clinical trial | Nakajima, Shinichiro; Uchida, Hiroyuki; Bies, Robert R.; Caravaggio, Fernando; Suzuki, Takefumi; Plitman, Eric; Mar, Wanna; Gerretsen, Philip; Pollock, Bruce G.; Mulsant, Benoit H.; Mamo, David; Graff-Guerrero, Ariel |
| 2012 | Dopamine D2 receptor occupancy and cognition in schizophrenia : analysis of the CATIE data | Sakurai, Hitoshi; Bies, Robert R.; Stroup, Scott T.; Keefe, Richard S. E.; Rajji, Tarek K.; Suzuki, Takefumi; Mamo, David; Pollock, Bruce G.; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki |
| 2012 | Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia : a cross-sectional study | Mizuno, Yuya; Bies, Robert R.; Remington, Gary; Mamo, David; Suzuki, Takefumi; Pollock, Bruce G.; Tsuboi, Takashi; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki |
| 2013 | Dopamine D2/3 occupancy of ziprasidone across a day : a within-subject PET study | Suzuki, Takefumi; Graff-Guerrero, Ariel; Uchida, Hiroyuki; Remington, Gary; Caravaggio, Fernando; Borlido, Carol; Pollock, Bruce G.; Mulsant, Benoit H.; Deluca, Vincenzo; Ismail, Zahinoor; Mamo, David |
| 2011 | Effects of aging on 5‐HT2AR binding : a HRRT PET study with and without partial volume corrections | Uchida, Hiroyuki; Chow, Tiffany W.; Mamo, David; Kapur, Shitij; Mulsant, Benoit H.; Houle, Sylvain; Pollock, Bruce G.; Graff-Guerrero, Ariel |
| 2013 | Estimated dopamine D2 receptor occupancy and remission in schizophrenia : analysis of the CATIE data | Moriguchi, Sho; Bies, Robert R.; Remington, Gary; Suzuki, Takefumi; Mamo, David; Watanabe, Koichiro; Mimura, Masaru; Pollock, Bruce G.; Uchida, Hiroyuki |
| 2013 | Frontotemporoparietal asymmetry and lack of illness awareness in schizophrenia | Gerretsen, Philip; Chakravarty, M. Mallar; Mamo, David; Menon, Mahesh; Pollock, Bruce G.; Rajji, Tarek K.; Graff-Guerrero, Ariel |
| 2013 | Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia : analysis of the CATIE data | Tsuboi, Takashi; Bies, Robert R.; Suzuki, Takefumi; Mamo, David; Pollock, Bruce G.; Graff-Guerrero, Ariel; Mimura, Masaru; Uchida, Hiroyuki |
| 2015 | Illness denial in schizophrenia spectrum disorders : a function of left hemisphere dominance | Gerretsen, Philip; Menon, Mahesh; Chakravarty, M. Mallar; Lerch, Jason P.; Mamo, David; Remington, Gary; Pollock, Bruce G.; Graff-Guerrero, Ariel |
| 2014 | Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders : resting state functional connectivity | Gerretsen, Philip; Menon, Mahesh; Mamo, David; Fervaha, Gagan; Remington, Gary; Pollock, Bruce G.; Graff-Guerrero, Ariel |
| 2009 | An improved radiosynthesis of the muscarinic M2 radiopharmaceutical, [18 F] FP-TZTP | van Oosten, Erik M.; Wilson, Alan A.; Stephenson, Karin A.; Mamo, David; Pollock, Bruce G.; Mulsant, Benoit H.; Yudin, Andrei K.; Houle, Sylvain; Vasdev, Neil |
| 2009 | The intersection of pharmacology, imaging, and genetics in the development of personalized medicine | Gerretsen, Philip; Muller, Daniel J.; Tiwari, Arun; Mamo, David; Pollock, Bruce G. |
| 2010 | Is desire for social relationships mediated by the serotonergic system in the prefrontal cortex? An [18F] setoperone PET study | Gerretsen, Philip; Graff-Guerrero, Ariel; Menon, Mahesh; Pollock, Bruce G.; Kapur, Shitij; Vasdev, Neil; Houle, Sylvain; Mamo, David |
| 2016 | Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia : a positron emission tomography dopamine D2/3 receptor occupancy study | Fervaha, Gagan; Caravaggio, Fernando; Mamo, David; Mulsant, Benoit H.; Pollock, Bruce G.; Nakajima, Shinichiro; Gerretsen, Philip; Rajji, Tarek K.; Mar, Wanna; Iwata, Yusuke; Plitman, Eric; Chung, Jun Ku; Remington, Gary; Graff-Guerrero, Ariel |
| 2009 | Long-term stability of measuring D 2 receptors in schizophrenia patients treated with antipsychotics | Uchida, Hiroyuki; Graff-Guerrero, Ariel; Mulsant, Benoit H.; Pollock, Bruce G.; Mamo, David |
| 2009 | Predicting age‐specific dosing of antipsychotics | Uchida, Hiroyuki; Pollock, Bruce G.; Bies, Robert R.; Mamo, David |
| 2012 | Predicting plasma concentration of risperidone associated with dosage change : a population pharmacokinetic study | Uchida, Hiroyuki; Mamo, David; Pollock, Bruce G.; Suzuki, Takefumi; Tsunoda, Kenichi; Watanabe, Koichiro; Mimura, Masaru; Bies, Robert R. |
| 2015 | Predicting plasma olanzapine concentration following a change in dosage : a population pharmacokinetic study | Tsuboi, Takashi; Bies, Robert R.; Suzuki, Takefumi; Takeuchi, Hiroyoshi; Nakajima, Shinichiro; Graff-Guerrero, Ariel; Mamo, David; Caravaggio, Fernando; Plitman, Eric; Mimura, Masaru; Pollock, Bruce G.; Uchida, Hiroyuki |
| 2009 | Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT 2A) receptors in older, healthy adults | Chow, Tiffany W.; Mamo, David; Uchida, Hiroyuki; Graff- Guerrero, Ariel; Houle, Sylvain; Smith, Gwenn S.; Pollock, Bruce G.; Mulsant, Benoit H. |
| 2010 | Towards the development of new subtype-specific muscarinic receptor radiopharmaceuticals-radiosynthesis and ex vivo biodistribution of [18F] 3-(4-(2-(2-(2-fluoroethoxy) ethoxy) ethylthio)-1, 2, 5-thiadiazol-3-yl)-1-methyl-1, 2, 5, 6-tetrahydropyridine | van Oosten, Erik M.; Wilson, Alan A.; Mamo, David; Pollock, Bruce G.; Mulsant, Benoit H.; Houle, Sylvain; Vasdev, Neil |
| 2011 | Transient insight induction with electroconvulsive therapy in a patient with refractory schizophrenia : a case report and systematic literature review | Gerretsen, Philip; Diaz, Pablo; Mamo, David; Kavanagh, Doug; Menon, Mahesh; Pollock, Bruce G.; Graff-Guerrero, Ariel |
| 2014 | The VAGUS insight into psychosis scale-self-report and clinician-rated versions | Gerretsen, Philip; Remington, Gary; Borlido, Carol; Quilty, Lena; Hassan, Sabrina; Polsinelli, Gina; Teo, Celine; Mar, Wanna; Simon, Regina; Menon, Mahesh; Pothier, David D.; Nakajima, Shinichiro; Caravaggio, Fernando; Mamo, David; Rajji, Tarek K.; Mulsant, Benoit H.; Deluca, Vincenzo; Ganguli, Rohan; Pollock, Bruce G.; Graff-Guerrero, Ariel |
| 2017 | Vestibular stimulation improves insight into illness in schizophrenia spectrum disorders | Gerretsen, Philip; Pothier, David D.; Falls, Carolyn; Armstrong, Maxine; Balakumar, Thushanthi; Uchida, Hiroyuki; Mamo, David; Pollock, Bruce G.; Graff-Guerrero, Ariel |
